Home > Boards > US Listed > Miscellaneous > ZIOPHARM Oncology Inc (ZIOP)

Company managed to successfully convince one of the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Plegee Member Profile
 
Followed By 2
Posts 113
Boards Moderated 0
Alias Born 08/17/06
160x600 placeholder
 ISS Recommends Ziopharm Shareholders Vote for Change on WaterMill Asset Management’s WHITE Consent Card Business Wire - 11/25/2020 8:30:00 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/24/2020 4:46:01 PM
WaterMill Asset Management Sets the Record Straight Following Ziopharm’s Apparent Attempt to Mislead Shareholders & Rewrite... Business Wire - 11/24/2020 9:00:00 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/23/2020 5:24:16 PM
Ziopharm Releases Investor Presentation Highlighting Execution of Strategy and Substantial Board Refreshment to Enhance Share... GlobeNewswire Inc. - 11/20/2020 11:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/20/2020 6:01:35 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/19/2020 4:49:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/19/2020 4:47:21 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/19/2020 4:14:47 PM
WaterMill Asset Management Releases Presentation Detailing the Case for Urgent Change Atop Ziopharm Oncology Business Wire - 11/19/2020 9:30:00 AM
White Rock Capital Supports WaterMill's Case for Change at Ziopharm Oncology PR Newswire (US) - 11/19/2020 9:00:00 AM
Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Glioblastoma and DIPG at the 2... GlobeNewswire Inc. - 11/19/2020 9:00:00 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/18/2020 5:17:22 PM
Ziopharm Oncology Appoints Raffaele Baffa, M.D., Ph.D., as Chief Medical Officer GlobeNewswire Inc. - 11/17/2020 4:15:00 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/16/2020 2:49:22 PM
Ziopharm Oncology Appoints Mary Thistle to Board of Directors GlobeNewswire Inc. - 11/16/2020 8:30:00 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/13/2020 4:57:06 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/12/2020 3:08:10 PM
WaterMill Asset Management Releases Candid Q&As with Each of its Director Candidates for Election to Ziopharm Oncology’s Bo... Business Wire - 11/12/2020 9:00:00 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/5/2020 5:17:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 4:09:46 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2020 4:04:00 PM
WaterMill Asset Management Sends Letter to Ziopharm Oncology Shareholders Business Wire - 11/5/2020 9:05:00 AM
Proxy Statement - Non-management (definitive, Revised) (dfrn14a) Edgar (US Regulatory) - 11/4/2020 4:10:11 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/2/2020 5:18:48 PM
Plegee   Monday, 06/29/20 06:58:40 PM
Re: Plegee post# 1137
Post # of 1139 
Company managed to successfully convince one of the large investors to change their nay vote. All items passed with the exception of the issuance of additional shares. Apparently the concession for changing their vote was to make the point the company must produce before they get access to any additional funds. No more dilutive financing without results. Minor victory, but largely disappointed.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences